Identification of the Thyrotropin-Releasing Hormone (TRH) as a Novel Biomarker in the Prognosis for Acute Myeloid Leukemia

Identification of the Thyrotropin-Releasing Hormone (TRH) as a Novel Biomarker in the Prognosis for Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a biologically and genetically heterogeneous hematological malignance with an unsatisfactory risk stratification system. Recently, through the novel single-cell RNA sequencing technology, we revealed heterogeneous leukemia myeloblasts in <i>RUNX1-RUNX1T1</i&g...

Full description

Bibliographic Details
Main Authors: Yan Gao, Jia-Fan Zhou, Jia-Ying Mao, Lu Jiang, Xue-Ping Li
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Biomolecules
Subjects:
acute myeloid leukemia
biomarkers
<i>TRH</i> expression
prognosis
Online Access:https://www.mdpi.com/2218-273X/12/10/1359

Similar Items

Similar Items